7,8,9,10-TETRAHYDRO-6(5H)-PHENANTHRIDINONE
![]() |
- $160 - $527
- Product name: 7,8,9,10-TETRAHYDRO-6(5H)-PHENANTHRIDINONE
- CAS: 4514-04-9
- MF: C13H13NO
- MW: 199.25
- EINECS:
- MDL Number:MFCD05258144
- Synonyms:7,8,9,10-TETRAHYDRO-6(5H)-PHENANTHRIDINONE;1,2,3,4,9,10-Hexahydro-1-oxo-9-azaphenanthrene;7,8,9,10-tetrahydro-5H-phenanthridin-6-one;7,8,9,10-tetrahydrophenanthridin-6(5H)-one;MFCD05258144;5,6,7,8,9,10-Hexahydrophenanthridin-6-one;6(5H)-Phenanthridinone, 7,8,9,10-tetrahydro-
3 prices
Selected condition:
Brand
- Crysdot
- Matrix Scientific
Package
- 0.500g
- 1g
- 5g
- ManufacturerCrysdot
- Product numberCD11122020
- Product description7,8,9,10-Tetrahydrophenanthridin-6(5H)-one 97%
- Packaging5g
- Price$527
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number156215
- Product description7,8,9,10-Tetrahydrophenanthridin-6(5H)-one
- Packaging0.500g
- Price$160
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number156215
- Product description7,8,9,10-Tetrahydrophenanthridin-6(5H)-one
- Packaging1g
- Price$200
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Crysdot | CD11122020 | 7,8,9,10-Tetrahydrophenanthridin-6(5H)-one 97% | 5g | $527 | 2021-12-16 | Buy |
Matrix Scientific | 156215 | 7,8,9,10-Tetrahydrophenanthridin-6(5H)-one | 0.500g | $160 | 2021-12-16 | Buy |
Matrix Scientific | 156215 | 7,8,9,10-Tetrahydrophenanthridin-6(5H)-one | 1g | $200 | 2021-12-16 | Buy |
Properties
Melting point :266-268 °C(Solv: methanol (67-56-1))
Boiling point :418.1±38.0 °C(Predicted)
Density :1.20±0.1 g/cm3(Predicted)
pka :13.86±0.20(Predicted)
Boiling point :418.1±38.0 °C(Predicted)
Density :1.20±0.1 g/cm3(Predicted)
pka :13.86±0.20(Predicted)
Safety Information
Symbol(GHS): |
![]() |
|||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | |||||||||||||||||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
Precautionary statements: |
|